The findings enriched our understanding of the PPAR-γ effect on modulating kidney function and the pathogenesis of renal fibrosis and also provided novel insights into CKD therapies by targeting renal tubular molecules and signaling pathways. This evidence concerns the gene PPARG and chronic kidney disease.